AU2003292133A8 - Plasmodium falciparum virulence factor var o - Google Patents

Plasmodium falciparum virulence factor var o

Info

Publication number
AU2003292133A8
AU2003292133A8 AU2003292133A AU2003292133A AU2003292133A8 AU 2003292133 A8 AU2003292133 A8 AU 2003292133A8 AU 2003292133 A AU2003292133 A AU 2003292133A AU 2003292133 A AU2003292133 A AU 2003292133A AU 2003292133 A8 AU2003292133 A8 AU 2003292133A8
Authority
AU
Australia
Prior art keywords
plasmodium falciparum
virulence factor
var
factor var
virulence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003292133A
Other versions
AU2003292133A1 (en
Inventor
Odile Puijalon
Cecile Le Scanf
Graham Bentley
Sebastien Igonet
Cyril Badaut
Anne Lavergne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of AU2003292133A8 publication Critical patent/AU2003292133A8/en
Publication of AU2003292133A1 publication Critical patent/AU2003292133A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2003292133A 2002-10-25 2003-10-24 Plasmodium falciparum virulence factor var o Abandoned AU2003292133A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,409,897 2002-10-25
CA002409897A CA2409897A1 (en) 2002-10-25 2002-10-25 Plasmodium falciparum virulence factor var o
PCT/EP2003/013341 WO2004037856A2 (en) 2002-10-25 2003-10-24 Plasmodium falciparum virulence factor var o

Publications (2)

Publication Number Publication Date
AU2003292133A8 true AU2003292133A8 (en) 2004-05-13
AU2003292133A1 AU2003292133A1 (en) 2004-05-13

Family

ID=32111429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003292133A Abandoned AU2003292133A1 (en) 2002-10-25 2003-10-24 Plasmodium falciparum virulence factor var o

Country Status (3)

Country Link
AU (1) AU2003292133A1 (en)
CA (1) CA2409897A1 (en)
WO (1) WO2004037856A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011066995A1 (en) * 2009-12-05 2011-06-09 Universität Heidelberg Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5851296A (en) * 1995-04-27 1996-11-18 Affymax Technologies N.V. Malaria peptides and vaccines

Also Published As

Publication number Publication date
CA2409897A1 (en) 2004-04-25
AU2003292133A1 (en) 2004-05-13
WO2004037856A3 (en) 2004-07-29
WO2004037856A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
AU2003279836A8 (en) Exercise garment
EP1487546A4 (en) Exercise
EP1527714A4 (en) Chair
HK1061628A1 (en) Chair
AU2003298032A8 (en) Cane base
GB2395380B (en) Peak detector circuitry
EP1470574A4 (en) Enhanced photodetector
AU2003292133A8 (en) Plasmodium falciparum virulence factor var o
GB2396181B (en) Posts
AU155791S (en) Stand
GB2387348B (en) Flat-folding stand
CA94404S (en) Climber
TW566581U (en) Electro-therapy mouse
TW563558U (en) Slow descending chair
GB0215960D0 (en) Exerciser
PL113030U1 (en) Showcase
CA94484S (en) Chair
CA94735S (en) Chair
CA94734S (en) Chair
CA94486S (en) Chair
CA94732S (en) Chair
CA94733S (en) Chair
CA94731S (en) Chair
CA94774S (en) Chair base
CA94893S (en) Chair base

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase